Zoladex

Zoladex is a brand name of goserelin, approved by the FDA in the following formulation(s):

ZOLADEX (goserelin acetate - implant; implantation)

• 
  Manufacturer: ASTRAZENECA
  
  Approval date: December 29, 1989
  
  Strength(s): EQ 3.6MG BASE ^[RLD]


• 
  Manufacturer: ASTRAZENECA
  
  Approval date: January 11, 1996
  
  Strength(s): EQ 10.8MG BASE ^[RLD]

Has a generic version of Zoladex been approved?

No. There is currently no therapeutically equivalent version of Zoladex available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zoladex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Automatically operable safety shield system for syringes
  Patent 7,118,552
  Issued: October 10, 2006
  Inventor(s): Shaw; Derek J. & Law; Brian R.
  Assignee(s): AstraZeneca AB
  An automatically operable safety shield system for use with a syringe, the safety shield system including an holder having proximal and distal portions and defining an enclosure into which the syringe may be inserted, an outer shield having proximal and distal portions, mounted outwards from the inner holder being axially movable relative to the inner holder between retracted and extended positions, a spring positioned between a first detent on the inner holder and a second detent on the outer shield, and urging the outer shield to its extended position, the inner holder having at least one first opening and the outer shield having at least one first stop member, the first stop member being engageable with the first opening when the outer shield is in the retracted position, the inner holder having distal to the first opening at least one first indentation, the first stop member being engageable with the first indentation when the outer shield is in the extended position.
  
  Patent expiration dates:
  
  
  • April 13, 2022
    
    ✓ 
    Drug product
  
  



• 
  Automatically operable safety shield system for syringes
  Patent 7,220,247
  Issued: May 22, 2007
  Inventor(s): Shaw; Derek J & Law; Brian R
  Assignee(s): AstraZeneca AB
  An automatically operable safety shield system for use with a syringe that comprises an inner holder in which said syringe may be inserted and an outer shield mounted outwards from the inner holder axially movable between retracted and extended positions in which a spring positioned between said inner holder and said outer shield urging the outer shield to its extended position and the inner holder having at least one first opening, distally thereto, at least one first indentation, and the outer shield having at least one first stop member engageable with the opening when the outer shield is in the retracted position engageable with the first indentation when the outer shield is in the extended position and the outer shield may be released from its retracted position by action of a trigger positioned within the inner holder or by protrusion on the syringe plunger.
  
  Patent expiration dates:
  
  
  • April 9, 2022
    
    ✓ 
    Drug product
  
  



• 
  Automatically operable safety shield system for syringes
  Patent 7,500,964
  Issued: March 10, 2009
  Inventor(s): Shaw; Derek J. & Law; Brian R.
  Assignee(s): AstraZeneca AB
  An automatically operable safety shield system for use with a syringe that comprises an inner holder in which said syringe may be inserted and an outer shield mounted outwards from the inner holder axially movable between retracted and extended positions in which a spring positioned between said inner holder and said outer shield urging the outer shield to its extended position and the inner holder having at least one first opening, distally thereto, at least one first indentation, and the outer shield having at least one first stop member engageable with the opening when the outer shield is in the retracted position engageable with the first indentation when the outer shield is in the extended position and the outer shield may be released from its retracted position by action of a trigger positioned within the inner holder or by protrusion on the syringe plunger.
  
  Patent expiration dates:
  
  
  • February 26, 2021
    
    ✓ 
    Drug product
  
  

See also...

• Zoladex Consumer Information (Drugs.com)
• Zoladex Consumer Information (Wolters Kluwer)
• Zoladex Consumer Information (Cerner Multum)
• Zoladex Advanced Consumer Information (Micromedex)
• Zoladex AHFS DI Monographs (ASHP)
• Goserelin Consumer Information (Wolters Kluwer)
• Goserelin Consumer Information (Cerner Multum)
• Goserelin Subcutaneous Advanced Consumer Information (Micromedex)
• Goserelin Acetate AHFS DI Monographs (ASHP)